Breaking Health News: From Mpox to Cannabis Research
Recent health news covers various topics: a new mpox case in New York, promising results of Ozempic for alcohol use disorder, U.S. impact on global health funding, Robert F. Kennedy Jr.'s health nomination, innovative prostate cancer treatments, Brazil's cannabis cultivation research, Ventas' financial success, a new FDA-approved drug, and MediWound's trial initiation.
The Centers for Disease Control and Prevention confirmed a new mpox variant case in New York, isolating the patient while seeking contacts. Symptoms were improving without specific treatments.
Ozempic, a GLP-1 diabetes drug by Novo Nordisk, showed promise in reducing alcohol use disorder symptoms, according to a small trial.
The U.S. pause on foreign aid is impacting global health initiatives, said WHO Director-General Tedros Adhanom Ghebreyesus, urging the U.S. to reassess funding decisions.
ALSO READ
-
FDA Pushes for Testosterone Therapies for Women: Breaking Down Barriers
-
Pennsylvania's Measles Outbreak Sparks CDC Standoff Amid Rising Vaccine Concerns
-
Pennsylvania's Measles Crisis: A Public Health Standoff
-
Pennsylvania’s Measles Outbreak Spurs Clash with Federal Authorities
-
Global Health Updates: ByteDance AI Spin-off, Cancer Drug Expansion, and Vaccine Challenges
Google News